Federal Trial for NYC Shooting Suspect May Be Delayed Due to Death Penalty Issue
A pivotal hearing in the federal trial of Luigi Mangione, 27, who is accused of killing UnitedHealthcare CEO Brian Thompson, took place on Friday. Mangione's lawyers are trying to block the Justice Department from seeking the death penalty in his case.
The defense has filed a motion to dismiss two counts, including one that would take the death penalty off the table, if approved. The counts in question are murder through use of a firearm and a firearms offense. If the defense is successful in dismissing these counts, it could impact the trial date.
Mangione arrived at court on Friday, wearing a tan prison jumpsuit and shaking hands with his attorneys. A small group of his supporters gathered outside the Manhattan courthouse.
The hearing was mostly about the defense's motion to dismiss two of the counts against Mangione. Mangione's lawyers argued that the stalking charges are not "crimes of violence" as required by law to convict him on Counts Three and Four. However, prosecutors disagree, arguing that the stalking charges meet this requirement.
The judge stated that the outcome of the motion will impact the trial date. The trial date was not set for Friday, but all parties agreed to target jury selection in early September with a potential trial starting later in the fall or early winter if it is a capital case.
Mangione's defense team argues that the police search of his backpack was illegal, and evidence found inside should be excluded because police did not have a warrant. Mangione's lawyers also claim that authorities prejudiced the case by turning his arrest into a highly choreographed spectacle, declaring their desire to see him executed before formally indicting him.
Prosecutors deny these claims, stating there is no conflict of interest with Attorney General Pam Bondi due to her previous job with Ballard Partners, which included UnitedHealthcare's parent company. They argue that pretrial publicity is hardly a constitutional crisis and Mangione has pleaded not guilty to both federal and state charges.
A pivotal hearing in the federal trial of Luigi Mangione, 27, who is accused of killing UnitedHealthcare CEO Brian Thompson, took place on Friday. Mangione's lawyers are trying to block the Justice Department from seeking the death penalty in his case.
The defense has filed a motion to dismiss two counts, including one that would take the death penalty off the table, if approved. The counts in question are murder through use of a firearm and a firearms offense. If the defense is successful in dismissing these counts, it could impact the trial date.
Mangione arrived at court on Friday, wearing a tan prison jumpsuit and shaking hands with his attorneys. A small group of his supporters gathered outside the Manhattan courthouse.
The hearing was mostly about the defense's motion to dismiss two of the counts against Mangione. Mangione's lawyers argued that the stalking charges are not "crimes of violence" as required by law to convict him on Counts Three and Four. However, prosecutors disagree, arguing that the stalking charges meet this requirement.
The judge stated that the outcome of the motion will impact the trial date. The trial date was not set for Friday, but all parties agreed to target jury selection in early September with a potential trial starting later in the fall or early winter if it is a capital case.
Mangione's defense team argues that the police search of his backpack was illegal, and evidence found inside should be excluded because police did not have a warrant. Mangione's lawyers also claim that authorities prejudiced the case by turning his arrest into a highly choreographed spectacle, declaring their desire to see him executed before formally indicting him.
Prosecutors deny these claims, stating there is no conflict of interest with Attorney General Pam Bondi due to her previous job with Ballard Partners, which included UnitedHealthcare's parent company. They argue that pretrial publicity is hardly a constitutional crisis and Mangione has pleaded not guilty to both federal and state charges.